{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:01Z","timestamp":1792788181994,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"2021 Gansu Jiaoyu Jiebang Guashuai Project","award":["2021 jyjbgs-03"],"award-info":[{"award-number":["2021 jyjbgs-03"]}]},{"name":"Gansu Province Traditional Chinese Medicine Prevention and Treatment of Major Diseases Special Project","award":["GZKZD-2018-02"],"award-info":[{"award-number":["GZKZD-2018-02"]}]},{"name":"Gansu Province Major Science and Technology Special Project","award":["20ZD7FA002"],"award-info":[{"award-number":["20ZD7FA002"]}]},{"name":"2022 Gansu Province natural sciences fund","award":["22JR11RA128"],"award-info":[{"award-number":["22JR11RA128"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260869"],"award-info":[{"award-number":["82260869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360926"],"award-info":[{"award-number":["82360926"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2024 Gansu Province Outstanding Doctoral Project","award":["24JRRA569"],"award-info":[{"award-number":["24JRRA569"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myocardial fibrosis represents a terminal pathological outcome in numerous cardiovascular diseases and is mechanistically linked to glycolytic dysregulation. However, systematic reviews integrating multidimensional evidence remain scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to conduct a visual analysis of myocardial fibrosis and glycolysis research using CiteSpace and VOSviewer, quantifying research trends and key contributors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Literature on \u201cmyocardial fibrosis\u201d and \u201cglycolysis\u201d published between January 1, 2000, and December 31, 2024, was retrieved from the Web of Science, PubMed, and Scopus databases. After deduplication, 408 articles were included for analysis. CiteSpace and VOSviewer were employed to analyze data regarding countries, institutions, authors, and keywords.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 408 studies were included. Annual publications on myocardial fibrosis and glycolysis exhibited a fluctuating upward trend, increasing from 1 (2000) to 51 (2024). These publications were divided into three phases: Initial Exploration (2000\u20132003, 1 article per year), Slow Fluctuation (2004\u20132009, 3\u20135 articles per year), and Rapid Development (2010\u20132024). During the Rapid Development phase, publications surged from 25 in 2019 to 44 in 2020, peaked in 2021\u20132022 (45 and 48 articles, respectively), and rebounded to 51 in 2024. Key contributors: The U.S. (177 studies, 32% of global output) and China (115 studies, 20%) were the leading contributors, collectively accounting for 52% of total publications; top institutions were Univ. of Alberta (15 Myocardial fibrosis representstudies) and Univ. of Utah (14 studies); core authors included Archer, S.L. (10 studies) and Chen, J.-X. (8 studies), with Lopaschuk, G.D. topping co-citations (117). High-frequency keywords: \u201cheart failure\u201d (107), \u201cexpression\u201d (81), \u201cmetabolism\u201d (60), \u201cglycolysis\u201d (44); high-centrality ones: \u201ccardiac hypertrophy\u201d (0.25), \u201cfatty acid oxidation\u201d (0.21). Emerging frontiers: \u201cextracellular matrix\u201d (burst intensity\u2009=\u20093.01, 2021\u20132024), \u201cpulmonary hypertension\u201d (3.61, 2022\u20132024). Clustering analysis identified 10 clusters (Silhouette Value\u2009=\u20090.7628, Modularity Q\u2009=\u20090.5292), including #0 pulmonary arterial hypertension (2014) and #10 mitochondrial dysfunction (2019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our bibliometric analysis reveals three pivotal trends: (1) The U.S. (32%) and China (20%) lead international collaborative networks; (2) Glycolytic reprogramming, oxidative stress, and metabolic interventions are prevalent research focuses; (3) Mitochondrial dysfunction and extracellular matrix remodeling are emerging frontiers. These findings clarify the glycolysis-fibrosis axis and provide a framework for targeted anti-fibrotic therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08005-4","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:54:50Z","timestamp":1773770090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myocardial fibrosis and glycolysis: a bibliometric study and visualization analysis (2000\u20132024)"],"prefix":"10.1186","volume":"24","author":[{"given":"Qilin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linchan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"8005_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2014.08.027","volume":"79","author":"X Chen","year":"2015","unstructured":"Chen X, Qian Y, Wu S. The warburg effect: evolving interpretations of an established concept. Free Radic Biol Med. 2015;79:253\u201363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.08.027.","journal-title":"Free Radic Biol Med"},{"key":"8005_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/molecules29010075","volume":"29","author":"B Liu","year":"2023","unstructured":"Liu B, Lu Y, Taledaohan A, Qiao S, Li Q, Wang Y. The promoting role of HK II in tumor development and the research progress of its inhibitors. Mol (Basel). 2023;29:75. https:\/\/doi.org\/10.3390\/molecules29010075.","journal-title":"Mol (Basel)"},{"key":"8005_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/157340613804488297","volume":"9","author":"I Ali","year":"2013","unstructured":"Ali I, Wani WA, Saleem K, Wesselinova D, Syntheses. DNA binding and anticancer profiles of L-glutamic acid ligand and its copper(II) and ruthenium(III) complexes. Med Chem (Sharjah). 2013;9:11\u201321. https:\/\/doi.org\/10.2174\/157340613804488297.","journal-title":"Med Chem (Sharjah)"},{"key":"8005_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/polym12030598","volume":"12","author":"I Ali","year":"2020","unstructured":"Ali I, Alsehli M, Scotti L, Tullius Scotti M, Tsai S-T, Yu R-S, et al. Progress in polymeric nano-medicines for theranostic cancer treatment. Polymers. 2020;12:598. https:\/\/doi.org\/10.3390\/polym12030598.","journal-title":"Polymers"},{"key":"8005_CR5","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2174\/0929867323666160405111152","volume":"23","author":"I Ali","year":"2016","unstructured":"Ali I, Lone MN, Suhail M, Mukhtar SD, Asnin L. Advances in nanocarriers for anticancer drugs delivery. Curr Med Chem. 2016;23:2159\u201387. https:\/\/doi.org\/10.2174\/0929867323666160405111152.","journal-title":"Curr Med Chem"},{"key":"8005_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.micpath.2012.04.005","volume":"53","author":"I Ali","year":"2012","unstructured":"Ali I, Wani WA, Khan A, Haque A, Ahmad A, Saleem K, et al. Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its copper(II) and nickel(II) complexes with conventional antifungals. Microb Pathog. 2012;53:66\u201373. https:\/\/doi.org\/10.1016\/j.micpath.2012.04.005.","journal-title":"Microb Pathog"},{"key":"8005_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-025-01205-6","volume":"31","author":"W Zhang","year":"2025","unstructured":"Zhang W, Xia M, Li J, Liu G, Sun Y, Chen X, et al. Warburg effect and lactylation in cancer: mechanisms for chemoresistance. Mol Med. 2025;31:1\u201324. https:\/\/doi.org\/10.1186\/s10020-025-01205-6.","journal-title":"Mol Med"},{"key":"8005_CR8","doi-asserted-by":"publisher","first-page":"102374","DOI":"10.1016\/j.nantod.2024.102374","volume":"57","author":"X Sun","year":"2024","unstructured":"Sun X, Zhang S, Wang P, Guo J, Zhou M, Chen Q, et al. A molecularly tailored closed-loop tumor cell energy nanodepleter for cancer starvation therapy. Nano Today. 2024;57:102374. https:\/\/doi.org\/10.1016\/j.nantod.2024.102374.","journal-title":"Nano Today"},{"key":"8005_CR9","doi-asserted-by":"publisher","first-page":"eadc9465","DOI":"10.1126\/sciadv.adc9465","volume":"9","author":"M Fan","year":"2023","unstructured":"Fan M, Yang K, Wang X, Chen L, Gill PS, Ha T, et al. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci Adv. 2023;9:eadc9465. https:\/\/doi.org\/10.1126\/sciadv.adc9465.","journal-title":"Sci Adv"},{"key":"8005_CR10","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1164\/rccm.201504-0780OC","volume":"192","author":"N Xie","year":"2015","unstructured":"Xie N, Tan Z, Banerjee S, Cui H, Ge J, Liu R-M, et al. Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis. Am J Respir Crit Care Med. 2015;192:1462\u201374. https:\/\/doi.org\/10.1164\/rccm.201504-0780OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"8005_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai C-H, Pucino V, Ho P-C, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21:151\u201361. https:\/\/doi.org\/10.1038\/s41577-020-0406-2.","journal-title":"Nat Rev Immunol"},{"key":"8005_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1874192402115010006","volume":"15","author":"NP Kuspriyanti","year":"2021","unstructured":"Kuspriyanti NP, Ariyanto EF, Syamsunarno MRAA. Role of warburg effect in cardiovascular diseases: a potential treatment option. Open Cardiovasc Med J. 2021;15:6\u201317. https:\/\/doi.org\/10.2174\/1874192402115010006.","journal-title":"Open Cardiovasc Med J"},{"key":"8005_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1.","journal-title":"Nature"},{"key":"8005_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis. Circ Res. 2016;118:1021\u201340. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306565.","journal-title":"Circ Res"},{"key":"8005_CR15","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117:1450\u201388. https:\/\/doi.org\/10.1093\/cvr\/cvaa324.","journal-title":"Cardiovasc Res"},{"key":"8005_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","volume":"19","author":"X Zhao","year":"2020","unstructured":"Zhao X, Kwan JYY, Yip K, Liu PP, Liu F-F. Targeting metabolic dysregulation for fibrosis therapy. Nat Rev Drug Discov. 2020;19:57\u201375. https:\/\/doi.org\/10.1038\/s41573-019-0040-5.","journal-title":"Nat Rev Drug Discov"},{"key":"8005_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","volume":"123","author":"AA Gibb","year":"2018","unstructured":"Gibb AA, Hill BG. Metabolic coordination of physiological and pathological cardiac remodeling. Circ Res. 2018;123:107\u201328. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312017.","journal-title":"Circ Res"},{"key":"8005_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/CIRCRESAHA.119.315483","volume":"126","author":"J Ritterhoff","year":"2020","unstructured":"Ritterhoff J, Young S, Villet O, Shao D, Neto FC, Bettcher LF, et al. Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis. Circ Res. 2020;126:182\u201396. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315483.","journal-title":"Circ Res"},{"key":"8005_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03745-1","volume":"12","author":"M Liu","year":"2021","unstructured":"Liu M, Wei F, Wang J, Yu W, Shen M, Liu T, et al. Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1\u2009\u2013\u2009PD-L1\u2009+\u2009bregs through PD-L1\/PI3K\/AKT\/NF-\u03baB axis in breast cancer. Cell Death Dis. 2021;12:1\u201315. https:\/\/doi.org\/10.1038\/s41419-021-03745-1.","journal-title":"Cell Death Dis"},{"key":"8005_CR20","doi-asserted-by":"publisher","first-page":"173131","DOI":"10.1016\/j.ejphar.2020.173131","volume":"881","author":"L Lv","year":"2020","unstructured":"Lv L, Zheng N, Zhang L, Li R, Li Y, Yang R, et al. Metformin ameliorates cardiac conduction delay by regulating microRNA-1 in mice. Eur J Pharmacol. 2020;881:173131. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173131.","journal-title":"Eur J Pharmacol"},{"key":"8005_CR21","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","volume":"146","author":"M Packer","year":"2022","unstructured":"Packer M. Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling\/autophagy hypothesis. Circulation. 2022;146:1383\u2013405. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061732.","journal-title":"Circulation"},{"key":"8005_CR22","doi-asserted-by":"publisher","first-page":"1445037","DOI":"10.3389\/fphar.2024.1445037","volume":"15","author":"F Qiu","year":"2024","unstructured":"Qiu F, Li Y, Zhou L, Wu Y, Wu Y, Fan Z, et al. Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis. Front Pharmacol. 2024;15:1445037. https:\/\/doi.org\/10.3389\/fphar.2024.1445037.","journal-title":"Front Pharmacol"},{"key":"8005_CR23","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/ATVBAHA.123.319601","volume":"44","author":"X He","year":"2024","unstructured":"He X, Cantrell AC, Williams QA, Gu W, Chen Y, Chen J-X, et al. p53 acetylation exerts critical roles in pressure overload-induced coronary microvascular dysfunction and heart failure in mice. Arterioscler Thromb Vasc Biol. 2024;44:826\u201342. https:\/\/doi.org\/10.1161\/ATVBAHA.123.319601.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"8005_CR24","doi-asserted-by":"publisher","first-page":"102467","DOI":"10.1016\/j.arr.2024.102467","volume":"100","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang Y, Li H, Wang DW, Chen C. Insights into the post-translational modifications in heart failure. Ageing Res Rev. 2024;100:102467. https:\/\/doi.org\/10.1016\/j.arr.2024.102467.","journal-title":"Ageing Res Rev"},{"key":"8005_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/BJ20100142","volume":"429","author":"U Krus","year":"2010","unstructured":"Krus U, Kotova O, Sp\u00e9gel P, Hallgard E, Sharoyko VV, Vedin A, et al. Pyruvate dehydrogenase kinase 1 controls mitochondrial metabolism and insulin secretion in INS-1 832\/13 clonal beta-cells. Biochem J. 2010;429:205\u201313. https:\/\/doi.org\/10.1042\/BJ20100142.","journal-title":"Biochem J"},{"key":"8005_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/asj\/sjaa142","volume":"41","author":"A Pagani","year":"2021","unstructured":"Pagani A, Kirsch BM, Hopfner U, Aitzetmueller MM, Brett EA, Thor D, et al. Deferiprone stimulates aged dermal fibroblasts via HIF-1\u03b1 modulation. Aesthetic Surg J. 2021;41:514\u201324. https:\/\/doi.org\/10.1093\/asj\/sjaa142.","journal-title":"Aesthetic Surg J"},{"key":"8005_CR27","doi-asserted-by":"publisher","unstructured":"Tu B, Song K, Zhou Z-Y, Lin L-C, Liu Z-Y, Sun H, et al. SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis. Eur Heart J. 2025;ehaf130. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf130.","DOI":"10.1093\/eurheartj\/ehaf130"},{"key":"8005_CR28","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1021\/acsptsci.4c00240","volume":"7","author":"LTT Pham","year":"2024","unstructured":"Pham LTT, Mangmool S, Parichatikanond W. Sodium-glucose cotransporter 2 (SGLT2) inhibitors: guardians against mitochondrial dysfunction and endoplasmic reticulum stress in heart diseases. ACS Pharmacol Transl Sci. 2024;7:3279\u201398. https:\/\/doi.org\/10.1021\/acsptsci.4c00240.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"8005_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.actbio.2022.04.022","volume":"145","author":"X Meng","year":"2022","unstructured":"Meng X, Lu Z, Lv Q, Jiang Y, Zhang L, Wang Z. Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy. Acta Biomater. 2022;145:222\u201334. https:\/\/doi.org\/10.1016\/j.actbio.2022.04.022.","journal-title":"Acta Biomater"},{"key":"8005_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/wrr.13188","volume":"32","author":"X Liu","year":"2024","unstructured":"Liu X, Wang B. Histone lactylation regulates autophagy of hyperplastic scar fibroblasts by inhibiting the transcriptional activity of phosphatase and tensin homologue. Wound Repair Regen. 2024;32:725\u201334. https:\/\/doi.org\/10.1111\/wrr.13188.","journal-title":"Wound Repair Regen"},{"key":"8005_CR31","doi-asserted-by":"publisher","first-page":"L562","DOI":"10.1152\/ajplung.00389.2019","volume":"318","author":"RE McDowell","year":"2020","unstructured":"McDowell RE, Aulak KS, Almoushref A, Melillo CA, Brauer BE, Newman JE, et al. Platelet glycolytic metabolism correlates with hemodynamic severity in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2020;318:L562\u20139. https:\/\/doi.org\/10.1152\/ajplung.00389.2019.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"8005_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/ijmm.2024.5439","volume":"54","author":"M Chen","year":"2024","unstructured":"Chen M, Li H, Li Y, Luo Y, He Y, Shui X, et al. Glycolysis modulation: new therapeutic strategies to improve pulmonary hypertension (review). Int J Mol Med. 2024;54:115. https:\/\/doi.org\/10.3892\/ijmm.2024.5439.","journal-title":"Int J Mol Med"},{"key":"8005_CR33","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.117.028034","volume":"136","author":"P Caruso","year":"2017","unstructured":"Caruso P, Dunmore BJ, Schlosser K, Schoors S, Dos Santos C, Perez-Iratxeta C, et al. Identification of MicroRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding protein) and pyruvate kinase M2. Circulation. 2017;136:2451\u201367. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028034.","journal-title":"Circulation"},{"key":"8005_CR34","doi-asserted-by":"publisher","first-page":"L439","DOI":"10.1152\/ajplung.00083.2024","volume":"327","author":"MN Tuineau","year":"2024","unstructured":"Tuineau MN, Herbert LM, Garcia SM, Resta TC, Jernigan NL. Enhanced glycolysis causes extracellular acidification and activates acid-sensing ion channel 1a in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2024;327:L439\u201351. https:\/\/doi.org\/10.1152\/ajplung.00083.2024.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"8005_CR35","doi-asserted-by":"publisher","first-page":"L430","DOI":"10.1152\/ajplung.00305.2023","volume":"328","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Cabrera JTO, Tsuji-Hosokawa A, Ramirez FJ, Cai H, Yuan JX-J, et al. Enhanced lung endothelial glycolysis is implicated in the development of severe pulmonary hypertension in type 2 diabetes. Am J Physiol Lung Cell Mol Physiol. 2025;328:L430\u201342. https:\/\/doi.org\/10.1152\/ajplung.00305.2023.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"8005_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.07.003","volume":"207","author":"Z-Y Liu","year":"2023","unstructured":"Liu Z-Y, Song K, Tu B, Lin L-C, Sun H, Zhou Y, et al. Glycolytic reprogramming in organ fibrosis: new dynamics of the epigenetic landscape. Free Radic Biol Med. 2023;207:1\u201310. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.07.003.","journal-title":"Free Radic Biol Med"},{"key":"8005_CR37","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","volume":"126","author":"L Tian","year":"2020","unstructured":"Tian L, Wu D, Dasgupta A, Chen K-H, Mewburn J, Potus F, et al. Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis. Circ Res. 2020;126:1723\u201345. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316443.","journal-title":"Circ Res"},{"key":"8005_CR38","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","volume":"120","author":"Q Sun","year":"2024","unstructured":"Sun Q, Karwi QG, Wong N, Lopaschuk GD. Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond. Cardiovasc Res. 2024;120:1996\u20132016. https:\/\/doi.org\/10.1093\/cvr\/cvae231.","journal-title":"Cardiovasc Res"},{"key":"8005_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00109-009-0524-6","volume":"88","author":"L Piao","year":"2010","unstructured":"Piao L, Fang Y-H, Cadete VJJ, Wietholt C, Urboniene D, Toth PT, et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med (Berl). 2010;88:47\u201360. https:\/\/doi.org\/10.1007\/s00109-009-0524-6.","journal-title":"J Mol Med (Berl)"},{"key":"8005_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/A:1021141812947","volume":"242","author":"A Vogt","year":"2004","unstructured":"Vogt A, Els\u00e4sser A, Nef H, Bode C, K\u00fcbler W, Schaper J. Increased glycolysis as protective adaptation of energy depleted, degenerating human hibernating myocardium. Mol Cell Biochem. 2004;242:101\u20137. https:\/\/doi.org\/10.1023\/A:1021141812947.","journal-title":"Mol Cell Biochem"},{"key":"8005_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2022.06.008","volume":"618","author":"D Liu","year":"2022","unstructured":"Liu D, Sun H, Li K, Zhao Z, Liu Z, Zhang G, et al. HIF-1\u03b1 mediates renal fibrosis by regulating metabolic remodeling of renal tubule epithelial cells. Biochem Biophys Res Commun. 2022;618:15\u201323. https:\/\/doi.org\/10.1016\/j.bbrc.2022.06.008.","journal-title":"Biochem Biophys Res Commun"},{"key":"8005_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tibs.2019.12.004","volume":"45","author":"MV Liberti","year":"2020","unstructured":"Liberti MV, Locasale JW. Histone lactylation: a new role for glucose metabolism. Trends Biochem Sci. 2020;45:179\u201382. https:\/\/doi.org\/10.1016\/j.tibs.2019.12.004.","journal-title":"Trends Biochem Sci"},{"key":"8005_CR43","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","volume":"85","author":"WC Stanley","year":"2005","unstructured":"Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093\u2013129. https:\/\/doi.org\/10.1152\/physrev.00006.2004.","journal-title":"Physiol Rev"},{"key":"8005_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cmet.2014.01.004","volume":"19","author":"G Sutendra","year":"2014","unstructured":"Sutendra G, Michelakis ED. The metabolic basis of pulmonary arterial hypertension. Cell Metab. 2014;19:558\u201373. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.004.","journal-title":"Cell Metab"},{"key":"8005_CR45","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00109-013-1059-4","volume":"91","author":"G Sutendra","year":"2013","unstructured":"Sutendra G, Dromparis P, Paulin R, Zervopoulos S, Haromy A, Nagendran J, et al. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mol Med (Berl). 2013;91:1315\u201327. https:\/\/doi.org\/10.1007\/s00109-013-1059-4.","journal-title":"J Mol Med (Berl)"},{"key":"8005_CR46","doi-asserted-by":"publisher","first-page":"31ra34","DOI":"10.1126\/scitranslmed.3000677","volume":"2","author":"ED Michelakis","year":"2010","unstructured":"Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, et al. Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med. 2010;2:31ra34. https:\/\/doi.org\/10.1126\/scitranslmed.3000677.","journal-title":"Sci Transl Med"},{"key":"8005_CR47","doi-asserted-by":"publisher","first-page":"44ra58","DOI":"10.1126\/scitranslmed.3001327","volume":"2","author":"G Sutendra","year":"2010","unstructured":"Sutendra G, Bonnet S, Rochefort G, Haromy A, Folmes KD, Lopaschuk GD, et al. Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension. Sci Transl Med. 2010;2:44ra58. https:\/\/doi.org\/10.1126\/scitranslmed.3001327.","journal-title":"Sci Transl Med"},{"key":"8005_CR48","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.108.832915","volume":"119","author":"J Yan","year":"2009","unstructured":"Yan J, Young ME, Cui L, Lopaschuk GD, Liao R, Tian R. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation. 2009;119:2818\u201328. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.832915.","journal-title":"Circulation"},{"key":"8005_CR49","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00109-010-0670-x","volume":"88","author":"P Dromparis","year":"2010","unstructured":"Dromparis P, Sutendra G, Michelakis ED. The role of mitochondria in pulmonary vascular remodeling. J Mol Med (Berl). 2010;88:1003\u201310. https:\/\/doi.org\/10.1007\/s00109-010-0670-x.","journal-title":"J Mol Med (Berl)"},{"key":"8005_CR50","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tox.2010.01.019","volume":"270","author":"RA Carvalho","year":"2010","unstructured":"Carvalho RA, Sousa RPB, Cadete VJJ, Lopaschuk GD, Palmeira CMM, Bjork JA, et al. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy. Toxicology. 2010;270:92\u20138. https:\/\/doi.org\/10.1016\/j.tox.2010.01.019.","journal-title":"Toxicology"},{"key":"8005_CR51","doi-asserted-by":"publisher","first-page":"e0236457","DOI":"10.1371\/journal.pone.0236457","volume":"15","author":"J Groenendyk","year":"2020","unstructured":"Groenendyk J, Wang Q, Wagg C, Lee D, Robinson A, Barr A, et al. Selective enhancement of cardiomyocyte efficiency results in a pernicious heart condition. PLoS ONE. 2020;15:e0236457. https:\/\/doi.org\/10.1371\/journal.pone.0236457.","journal-title":"PLoS ONE"},{"key":"8005_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yjmcc.2014.02.011","volume":"72","author":"RO Pereira","year":"2014","unstructured":"Pereira RO, Wende AR, Olsen C, Soto J, Rawlings T, Zhu Y, et al. GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure. J Mol Cell Cardiol. 2014;72:95\u2013103. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.02.011.","journal-title":"J Mol Cell Cardiol"},{"key":"8005_CR53","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41374-018-0104-x","volume":"99","author":"ME Pepin","year":"2019","unstructured":"Pepin ME, Ha C-M, Crossman DK, Litovsky SH, Varambally S, Barchue JP, et al. Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure. Lab Investig. 2019;99:371\u201386. https:\/\/doi.org\/10.1038\/s41374-018-0104-x.","journal-title":"Lab Investig"},{"key":"8005_CR54","doi-asserted-by":"publisher","first-page":"8716","DOI":"10.1074\/jbc.M509890200","volume":"281","author":"AS Augustus","year":"2006","unstructured":"Augustus AS, Buchanan J, Park T-S, Hirata K, Noh H-L, Sun J, et al. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem. 2006;281:8716\u201323. https:\/\/doi.org\/10.1074\/jbc.M509890200.","journal-title":"J Biol Chem"},{"key":"8005_CR55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1161\/CIRCULATIONAHA.119.044452","volume":"142","author":"R Badolia","year":"2020","unstructured":"Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, et al. The role of nonglycolytic glucose metabolism in myocardial recovery upon mechanical unloading and circulatory support in chronic heart failure. Circulation. 2020;142:259\u201374. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044452.","journal-title":"Circulation"},{"key":"8005_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cjca.2015.01.023","volume":"31","author":"JJ Ryan","year":"2015","unstructured":"Ryan JJ, Huston J, Kutty S, Hatton ND, Bowman L, Tian L, et al. Right ventricular adaptation and failure in pulmonary arterial hypertension. Can J Cardiol. 2015;31:391\u2013406. https:\/\/doi.org\/10.1016\/j.cjca.2015.01.023.","journal-title":"Can J Cardiol"},{"key":"8005_CR57","doi-asserted-by":"publisher","first-page":"48085","DOI":"10.1074\/jbc.M405510200","volume":"279","author":"RV Donthi","year":"2004","unstructured":"Donthi RV, Ye G, Wu C, McClain DA, Lange AJ, Epstein PN. Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity. J Biol Chem. 2004;279:48085\u201390. https:\/\/doi.org\/10.1074\/jbc.M405510200.","journal-title":"J Biol Chem"},{"key":"8005_CR58","doi-asserted-by":"publisher","first-page":"e0118974","DOI":"10.1371\/journal.pone.0118974","volume":"10","author":"J Shibayama","year":"2015","unstructured":"Shibayama J, Yuzyuk TN, Cox J, Makaju A, Miller M, Lichter J, et al. Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study. PLoS ONE. 2015;10:e0118974. https:\/\/doi.org\/10.1371\/journal.pone.0118974.","journal-title":"PLoS ONE"},{"key":"8005_CR59","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s42255-020-00288-1","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Taufalele PV, Cochran JD, Robillard-Frayne I, Marx JM, Soto J, et al. Mitochondrial pyruvate carriers are required for myocardial stress adaptation. Nat Metab. 2020;2:1248\u201364. https:\/\/doi.org\/10.1038\/s42255-020-00288-1.","journal-title":"Nat Metab"},{"key":"8005_CR60","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.121.18684","volume":"79","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Shu D, Gong X, Lu M, Feng Q, Zeng X-B, et al. Platelet-derived TGF (transforming growth factor)-\u03b21 enhances the aerobic glycolysis of pulmonary arterial smooth muscle cells by PKM2 (pyruvate kinase muscle isoform 2) upregulation. Hypertens. 2022;79:932\u201345. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.18684.","journal-title":"Hypertens"},{"issue":"Suppl 4","key":"8005_CR61","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/j.healun.2020.01.1048","volume":"39","author":"R Badolia","year":"2020","unstructured":"Badolia R, Ramadurai D, Taleb I, Shankar T, Thodou A, Yin M, et al. The role of non-glycolytic glucose metabolism in myocardial recovery following mechanical unloading and circulatory support in chronic heart failure. J Heart Lung Transpl. 2020;39(Suppl 4):S. https:\/\/doi.org\/10.1016\/j.healun.2020.01.1048.","journal-title":"J Heart Lung Transpl"},{"key":"8005_CR62","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/CM9.0000000000000955","volume":"133","author":"L Wang","year":"2020","unstructured":"Wang L, He H-W, Xing Z-Q, Tang B, Zhou X. Lactate induces alternative polarization (M2) of macrophages under lipopolysaccharide stimulation in vitro through G-protein coupled receptor 81. Chin Med J (Engl). 2020;133:1761\u20133. https:\/\/doi.org\/10.1097\/CM9.0000000000000955.","journal-title":"Chin Med J (Engl)"},{"key":"8005_CR63","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022;603:159\u201365. https:\/\/doi.org\/10.1038\/s41586-022-04431-8.","journal-title":"Nature"},{"key":"8005_CR64","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1093\/eurheartj\/ehad389","volume":"44","author":"AK Pandey","year":"2023","unstructured":"Pandey AK, Bhatt DL, Pandey A, Marx N, Cosentino F, Pandey A, et al. Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction. Eur Heart J. 2023;44:3640\u201351. https:\/\/doi.org\/10.1093\/eurheartj\/ehad389.","journal-title":"Eur Heart J"},{"key":"8005_CR65","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.120.052186","volume":"143","author":"MMY Lee","year":"2021","unstructured":"Lee MMY, Brooksbank KJM, Wetherall K, Mangion K, Roditi G, Campbell RT, et al. Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation. 2021;143:516\u201325. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052186.","journal-title":"Circulation"},{"key":"8005_CR66","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.2147\/DDDT.S269514","volume":"14","author":"N Li","year":"2020","unstructured":"Li N, Zhou H. SGLT2 inhibitors: a novel player in the treatment and prevention of diabetic cardiomyopathy. Drug Des Dev Ther. 2020;14:4775\u201388. https:\/\/doi.org\/10.2147\/DDDT.S269514.","journal-title":"Drug Des Dev Ther"},{"key":"8005_CR67","doi-asserted-by":"publisher","first-page":"E330","DOI":"10.1152\/ajpendo.00159.2022","volume":"324","author":"H Fan","year":"2023","unstructured":"Fan H, Yang F, Xiao Z, Luo H, Chen H, Chen Z, et al. Lactylation: novel epigenetic regulatory and therapeutic opportunities. Am J Physiol Endocrinol Metab. 2023;324:E330\u20138. https:\/\/doi.org\/10.1152\/ajpendo.00159.2022.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"8005_CR68","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10741-018-9694-z","volume":"23","author":"H Tao","year":"2018","unstructured":"Tao H, Song Z-Y, Ding X-S, Yang J-J, Shi K-H, Li J. Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification. Heart Fail Rev. 2018;23:789\u201399. https:\/\/doi.org\/10.1007\/s10741-018-9694-z.","journal-title":"Heart Fail Rev"},{"key":"8005_CR69","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.2147\/JIR.S459185","volume":"17","author":"S Liu","year":"2024","unstructured":"Liu S, Yang T, Jiang Q, Zhang L, Shi X, Liu X, et al. Lactate and lactylation in sepsis: a comprehensive review. J Inflamm Res. 2024;17:4405\u201317. https:\/\/doi.org\/10.2147\/JIR.S459185.","journal-title":"J Inflamm Res"},{"key":"8005_CR70","doi-asserted-by":"publisher","first-page":"107673","DOI":"10.1016\/j.carpath.2024.107673","volume":"73","author":"A Fatehi Hassanabad","year":"2024","unstructured":"Fatehi Hassanabad A, Zarzycki AN, Patel VB, Fedak PWM. Current concepts in the epigenetic regulation of cardiac fibrosis. Cardiovasc Pathol. 2024;73:107673. https:\/\/doi.org\/10.1016\/j.carpath.2024.107673.","journal-title":"Cardiovasc Pathol"},{"key":"8005_CR71","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","volume":"35","author":"H Rho","year":"2023","unstructured":"Rho H, Terry AR, Chronis C, Hay N. Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis. Cell Metab. 2023;35:1406\u2013e14238. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.013.","journal-title":"Cell Metab"},{"key":"8005_CR72","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fphys.2020.00301","volume":"11","author":"AD Okyere","year":"2020","unstructured":"Okyere AD, Tilley DG. Leukocyte-dependent regulation of cardiac fibrosis. Front Physiol. 2020;11:301. https:\/\/doi.org\/10.3389\/fphys.2020.00301.","journal-title":"Front Physiol"},{"key":"8005_CR73","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1096\/fj.201902155R","volume":"34","author":"CD Bhedi","year":"2020","unstructured":"Bhedi CD, Nasirova S, Toksoz D, Warburton R, Morine K, Kapur N, et al. Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling. FASEB J. 2020;34:930\u201344. https:\/\/doi.org\/10.1096\/fj.201902155R.","journal-title":"FASEB J"},{"key":"8005_CR74","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/ijms24021784","volume":"24","author":"M Scuruchi","year":"2023","unstructured":"Scuruchi M, Mannino F, Imbesi C, Pallio G, Vermiglio G, Bagnato G, et al. Biglycan involvement in heart fibrosis: modulation of adenosine 2A receptor improves damage in immortalized cardiac fibroblasts. Int J Mol Sci. 2023;24:1784. https:\/\/doi.org\/10.3390\/ijms24021784.","journal-title":"Int J Mol Sci"},{"key":"8005_CR75","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.3390\/ijms23084302","volume":"23","author":"T Methatham","year":"2022","unstructured":"Methatham T, Nagai R, Aizawa K. A new hypothetical concept in metabolic understanding of cardiac fibrosis: glycolysis combined with TGF-\u03b2 and KLF5 signaling. Int J Mol Sci. 2022;23:4302. https:\/\/doi.org\/10.3390\/ijms23084302.","journal-title":"Int J Mol Sci"},{"key":"8005_CR76","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1089\/ars.2009.2930","volume":"13","author":"N Khaper","year":"2010","unstructured":"Khaper N, Bryan S, Dhingra S, Singal R, Bajaj A, Pathak CM, et al. Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid Redox Signal. 2010;13:1033\u201349. https:\/\/doi.org\/10.1089\/ars.2009.2930.","journal-title":"Antioxid Redox Signal"},{"key":"8005_CR77","doi-asserted-by":"publisher","first-page":"102820","DOI":"10.1016\/j.redox.2023.102820","volume":"65","author":"Z-Y Liu","year":"2023","unstructured":"Liu Z-Y, Song K, Tu B, Lin L-C, Sun H, Zhou Y, et al. Crosstalk between oxidative stress and epigenetic marks: new roles and therapeutic implications in cardiac fibrosis. Redox Biol. 2023;65:102820. https:\/\/doi.org\/10.1016\/j.redox.2023.102820.","journal-title":"Redox Biol"},{"key":"8005_CR78","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1042\/CS20190475","volume":"133","author":"L Matilla","year":"2019","unstructured":"Matilla L, Ibarrola J, Arrieta V, Garcia-Pe\u00f1a A, Martinez-Martinez E, S\u00e1daba R, et al. Soluble ST2 promotes oxidative stress and inflammation in cardiac fibroblasts: an in vitro and in vivo study in aortic stenosis. Clin Sci (Lond). 2019;133:1537\u201348. https:\/\/doi.org\/10.1042\/CS20190475.","journal-title":"Clin Sci (Lond)"},{"key":"8005_CR79","doi-asserted-by":"publisher","first-page":"420","DOI":"10.7150\/ijms.5723","volume":"10","author":"K Ma","year":"2013","unstructured":"Ma K, Liu J, Ni J, Zhang Y, Lv L, Tang R, et al. Inflammatory stress exacerbates the progression of cardiac fibrosis in high-fat-fed apolipoprotein E knockout mice via endothelial-mesenchymal transition. Int J Med Sci. 2013;10:420\u20136. https:\/\/doi.org\/10.7150\/ijms.5723.","journal-title":"Int J Med Sci"},{"key":"8005_CR80","doi-asserted-by":"publisher","first-page":"19571","DOI":"10.1074\/jbc.M114.550624","volume":"289","author":"NA Bracey","year":"2014","unstructured":"Bracey NA, Gershkovich B, Chun J, Vilaysane A, Meijndert HC, Wright JR, et al. Mitochondrial NLRP3 protein induces reactive oxygen species to promote smad protein signaling and fibrosis independent from the inflammasome. J Biol Chem. 2014;289:19571\u201384. https:\/\/doi.org\/10.1074\/jbc.M114.550624.","journal-title":"J Biol Chem"},{"key":"8005_CR81","doi-asserted-by":"publisher","first-page":"48","DOI":"10.18585\/inabj.v16i1.2776","volume":"16","author":"M Ridwan","year":"2024","unstructured":"Ridwan M, Dimiati H, Syukri M, Lesmana R, Zaini LM. Effects of SGLT2-inhibitor on the expression of MicroRNA-21, transforming growth factor-\u03b21, and matrix metalloproteinase-2 in the process of cardiac fibrosis in hyperglycemic model rats. Indones Biomed J. 2024;16:48\u201355. https:\/\/doi.org\/10.18585\/inabj.v16i1.2776.","journal-title":"Indones Biomed J"},{"key":"8005_CR82","doi-asserted-by":"publisher","first-page":"1291450","DOI":"10.3389\/fcvm.2023.1291450","volume":"10","author":"S Su","year":"2023","unstructured":"Su S, Ji X, Li T, Teng Y, Wang B, Han X, et al. The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy. Front Cardiovasc Med. 2023;10:1291450. https:\/\/doi.org\/10.3389\/fcvm.2023.1291450.","journal-title":"Front Cardiovasc Med"},{"key":"8005_CR83","doi-asserted-by":"publisher","first-page":"867075","DOI":"10.3389\/fneph.2022.867075","volume":"2","author":"A Granata","year":"2022","unstructured":"Granata A, Pesce F, Iacoviello M, Anzaldi M, Amico F, Catalano M, et al. SGLT2 inhibitors: a broad impact therapeutic option for the nephrologist. Front Nephrol. 2022;2:867075. https:\/\/doi.org\/10.3389\/fneph.2022.867075.","journal-title":"Front Nephrol"},{"key":"8005_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.06.013","volume":"206","author":"Y Li","year":"2023","unstructured":"Li Y, Liu X, Wan L, Han B, Ma S, Pan H, et al. Metformin suppresses cardiac fibroblast proliferation under high-glucose conditions via regulating the mitochondrial complex I protein grim-19 involved in the Sirt1\/Stat3 signaling pathway. Free Radic Biol Med. 2023;206:1\u201312. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.06.013.","journal-title":"Free Radic Biol Med"},{"key":"8005_CR85","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1042\/BST20191255","volume":"48","author":"C Krstevski","year":"2020","unstructured":"Krstevski C, Cohen CD, Dona MSI, Pinto AR. New perspectives of the cardiac cellular landscape: mapping cellular mediators of cardiac fibrosis using single-cell transcriptomics. Biochem Soc Trans. 2020;48:2483\u201393. https:\/\/doi.org\/10.1042\/BST20191255.","journal-title":"Biochem Soc Trans"},{"key":"8005_CR86","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.117.030742","volume":"138","author":"MM Gladka","year":"2018","unstructured":"Gladka MM, Molenaar B, de Ruiter H, van der Elst S, Tsui H, Versteeg D, et al. Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation. Circulation. 2018;138:166\u201380. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030742.","journal-title":"Circulation"},{"key":"8005_CR87","doi-asserted-by":"publisher","first-page":"11257","DOI":"10.2147\/JIR.S475633","volume":"17","author":"J Rao","year":"2024","unstructured":"Rao J, Wang X, Wang Z. Integration of microarray data and single-cell sequencing analysis to explore key genes associated with macrophage infiltration in heart failure. J Inflamm Res. 2024;17:11257\u201374. https:\/\/doi.org\/10.2147\/JIR.S475633.","journal-title":"J Inflamm Res"},{"key":"8005_CR88","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1093\/cvr\/cvad140","volume":"119","author":"B Kattih","year":"2023","unstructured":"Kattih B, Boeckling F, Shumliakivska M, Tombor L, Rasper T, Schmitz K, et al. Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease. Cardiovasc Res. 2023;119:2550\u201362. https:\/\/doi.org\/10.1093\/cvr\/cvad140.","journal-title":"Cardiovasc Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08005-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:22:37Z","timestamp":1777000957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08005-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8005"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08005-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships that could be perceived as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"585"}}